Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

teva pharma ag - budesonidum - suspension zur inhalation - budesonidum 0.5 mg, polysorbatum 80, natrii chloridum, natrii citras dihydricus, acidum citricum monohydricum, dinatrii edetas, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - antiasthmatikum - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

reckitt benckiser (switzerland) ag - natrii alginas, natrii hydrogenocarbonas, calcio carbonas - suspension zum einnehmen im beutel - natrii alginas 500 mg, natrii hydrogenocarbonas 267 mg, calcii carbonas 160 mg, carbomerum 974p, natrii hydroxidum ad ph, aqua purificata, aromatica (minze), saccharinum natricum, propylis parahydroxybenzoas 6 mg, e 218 40 mg, ad suspensionem pro 10 ml corresp. natrium 142.6 mg. - antacidum - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

effik sa - riluzolum - suspension buvable - riluzolum 50 mg, arom.: saccharinum natricum, excipiens la sospensione per 10 ml. - la sclerosi laterale amiotrofica (sla) - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - haemagglutininum influenzae a (h1n1) (virus souche a/michigan/45/2015 (h1n1)-like: reassortant virus nymc x-275 derived from a/michigan/45/2015), haemagglutininum influenzae a (h3n2) (virus souche a/singapore/infimh-16-0019/2016 (h3n2)-like: reassortant virus ivr-186 derived from a/singapore/infimh-16-0019/2016 ), haemagglutininum influenzae b (virus souche b/colorado/06/2017-like: reassortant virus nymc bx-69a derived from b/maryland/15/2016 (victoria lineage)) - suspension injectable en seringue préremplie - haemagglutininum influenzae a (h1n1) (virus souche a/michigan/45/2015 (h1n1)-like: reassortant virus nymc x-275 derived from a/michigan/45/2015) 60 µg, haemagglutininum influenzae a (h3n2) (virus souche a/singapore/infimh-16-0019/2016 (h3n2)-like: reassortant virus ivr-186 derived from a/singapore/infimh-16-0019/2016 ) 60 µg, haemagglutininum influenzae b (virus souche b/phuket/3073/2013 (yamagata lineage) (wild type)) 60 µg, haemagglutininum influenzae b (virus souche b/colorado/06/2017-like: reassortant virus nymc bx-69a derived from b/maryland/15/2016 (victoria lineage)) 60 µg, natrii chloridum, dinatrii phosphas, natrii dihydrogenophosphas anhydricus, octoxinolum-9, aqua ad iniectabile q.s. ad suspensionem pro 0.7 ml corresp. natrium 2.72 mg. - immunisation active contre l'influenza, dès 65 ans - vaccini

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - haemagglutininum influenzae a (h1n1) (virus souche a/victoria/2570/2019 (h1n1)-like: reassortant virus ivr-215 derived from a/victoria/2570/2019), haemagglutininum influenzae a (h3n2) (virus souche a/darwin/9/2021 (h3n2)-like: reassortant virus san-010 derived from a/darwin/9/2021), haemagglutininum influenzae b (virus souche b/austria/1359417/2021-like: derived from b/michigan/01/2021 (victoria lineage)(wild type)) - suspension injectable en seringue préremplie - haemagglutininum influenzae a (h1n1) (virus souche a/victoria/2570/2019 (h1n1)-like: reassortant virus ivr-215 derived from a/victoria/2570/2019) 60 µg, haemagglutininum influenzae a (h3n2) (virus souche a/darwin/9/2021 (h3n2)-like: reassortant virus san-010 derived from a/darwin/9/2021) 60 µg, haemagglutininum influenzae b (virus souche b/austria/1359417/2021-like: derived from b/michigan/01/2021 (victoria lineage)(wild type)) 60 µg, haemagglutininum influenzae b (virus souche b/phuket/3073/2013 (yamagata lineage) (wild type)) 60 µg, natrii chloridum, dinatrii phosphas, natrii dihydrogenophosphas anhydricus, octoxinolum-9, aqua ad iniectabile q.s. ad suspensionem pro 0.7 ml corresp. natrium 2.72 mg. - immunisation active contre l'influenza, dès 65 ans - vaccini

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - toxoidum diphtheriae, toxoidum tetani, toxoidum pertussis, haemagglutininum filamentosum, pertactinum, fimbriae types 2 et 3, virus poliomyelitis typus 1 inactivatus, virus poliomyelitis typus 2 inactivatus, virus poliomyelitis typus 3 inactivatus - suspension injectable en seringue préremplie - toxoidum diphtheriae min. 2 u.i., toxoidum tetani min. 20 u.i., toxoidum pertussis 2.5 µg, haemagglutininum filamentosum 5 µg, pertactinum 3 µg, fimbriae types 2 et 3 5 µg, virus poliomyelitis typus 1 inactivatus 29 u., virus poliomyelitis typus 2 inactivatus 7 u., virus poliomyelitis typus 3 inactivatus 26 u., aluminii phosphas corresp. aluminium 0.33 mg, phenoxyethanolum, ethanolum 1.01 mg, polysorbatum 80, aqua ad iniectabile, ad suspensionem pro 0.5 ml corresp. ethanolum 0.3 % v/v, residui: formaldehydum, glutaralum, streptomycinum, neomycinum, polymyxinum b, albuminum seri bovis. - vaccination de rappel contre la diphtérie, le tétanos, la coqueluche et la poliomyélite chez les personnes à partir du 4ème anniversaire - vaccini

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - toxoidum diphtheriae, toxoidum tetani, toxoidum pertussis, haemagglutininum filamentosum, pertactinum, fimbriae types 2 et 3 - suspension injectable en seringue préremplie - toxoidum diphtheriae min. 2 u.i., toxoidum tetani min. 20 u.i., toxoidum pertussis 2.5 µg, haemagglutininum filamentosum 5 µg, pertactinum 3 µg, fimbriae types 2 et 3 5 µg, aluminii phosphas corresp. aluminium 0.33 mg, phenoxyethanolum, aqua ad iniectabile, ad suspensionem pro 0.5 ml, residui: formaldehydum, glutaralum. - vaccination de rappel contre la diphtérie, le tétanos et la coqueluche chez les personnes à partir du 4ème anniversaire - vaccini

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - haemagglutininum influenzae a (h1n1) (virus souche a/victoria/4897/2022 (h1n1)-like: reassortant virus ivr-238 derived from a/victoria/4897/2022), haemagglutininum influenzae a (h3n2) (virus souche a/darwin/9/2021 (h3n2)-like: reassortant virus san-010 derived from a/darwin/9/2021), haemagglutininum influenzae b (virus souche b/austria/1359417/2021-like: derived from b/michigan/01/2021 (victoria lineage)(wild type)) - suspension injectable en seringue préremplie - haemagglutininum influenzae a (h1n1) (virus souche a/victoria/4897/2022 (h1n1)-like: reassortant virus ivr-238 derived from a/victoria/4897/2022) 60 µg, haemagglutininum influenzae a (h3n2) (virus souche a/darwin/9/2021 (h3n2)-like: reassortant virus san-010 derived from a/darwin/9/2021) 60 µg, haemagglutininum influenzae b (virus souche b/austria/1359417/2021-like: derived from b/michigan/01/2021 (victoria lineage)(wild type)) 60 µg, haemagglutininum influenzae b (virus souche b/phuket/3073/2013 (yamagata lineage) (wild type)) 60 µg, natrii chloridum, dinatrii phosphas, natrii dihydrogenophosphas anhydricus, octoxinolum-9, aqua ad iniectabile q.s. ad suspensionem pro 0.7 ml corresp. natrium 2.72 mg. - immunisation active contre l'influenza, dès 65 ans - vaccini

Taliansko - taliančina - AIFA (Agenzia Italiana del Farmaco)

bristol myers squibb s.r.l. - buspirone - buspirone

Taliansko - taliančina - AIFA (Agenzia Italiana del Farmaco)

a. menarini industrie farmaceutiche riunite s.r.l. - buspirone - buspirone